News & Events

Added to My Toolbox
Removed from My Toolbox
Added to My Toolbox
Removed from My Toolbox
Mar 31, 2014

Study Tests New Medication for Chronic Coronary Heart Disease

A new drug to reduce inflammation shows no added benefit in patients with stable heart disease.

Inflammation has been linked to heart disease in many large studies. Lp-PLA2, a marker of inflammation measured in the bloodstream, is blocked by a new medication called darapladib. However, according to a study presented at the American College of Cardiology’s 63rd Scientific Session, darapladib failed to show a survival benefit in patients who were already treated with optimal medications for their heart disease.

This study, known as STABILITY, enrolled 15,828 patients with stable heart disease in different countries. Half of them received the oral medication darapladib. The medication was generally well tolerated without major safety concerns during the 3.7 year follow-up period. Darapladib showed no significant benefit in reducing first heart attacks, stroke, or death from heart disease. The most common side effect of this medication was diarrhea, which led to stopping the drug among some participants.

Future studies are underway to see if patients that are suffering from heart attacks may receive additional benefits from treatment with darapladib.


Equally Aggressive Treatment Needed for Men and Women with Heart Disease

While risk factors may, study findings suggest plaque build-up in arteries is just as dangerous in all patients.

Detecting Clogged Arteries to Potentially Prevent Heart Disease

3–D testing finds nearly two-thirds of healthy, middle-aged adults have early signs of heart disease.

New Plaque Test Helps Identify High-Risk Heart Patients

Near-infrared spectroscopy (NIRS) helps identify heart disease patients at increased risk for heart attack and stroke, finds study.

Antidepressants Cut Heart Risks in Half

Study analyzes benefits of treatment for moderate to severe depression with and without statins.

Not All Plaque is Created Equal

Plaque density may prove an important factor when calculating risk for heart disease, heart attack and stroke, according to a recent study.